Arizona Tribune - Technology

NYSE - LSE

CMSC	0.18%	21.99	$
BCC	0.59%	75.93	$
RBGPF	0%	65.61	$
CMSD	-0.14%	22.15	$
GSK	4.4%	53.66	$
NGG	3.22%	82.85	$
AZN	5.79%	195.15	$
BTI	1.96%	61.77	$
RIO	1.13%	94.42	$
JRI	0.46%	13	$
RELX	1.72%	31.93	$
BP	3.34%	37.4	$
BCE	1.87%	21.42	$
VOD	1.06%	13.15	$
RYCEF	1.27%	19.75	$

Featured

Germany's Infineon opens major chip plant as EU seeks tech autonomy

German semiconductor giant Infineon opened a five-billion-euro ($5.7 billion) microchip plant Thursday, at a time Europe seeks to bolster its high-tech autonomy.

Bones of contention: More research needed on 'd'Artagnan corpse'

More research is needed to determine whether bones buried beneath a Dutch church belong to d'Artagnan, the swashbuckling French soldier who inspired the novel The Three Musketeers, officials said Thursday.

Last news

IEH Corporation Filed Form 10-Q for Fiscal Quarter Ended June 30, 2025

BROOKLYN, NY / ACCESS Newswire / August 13, 2025 / IEH Corporation (OTC:IEHC) yesterday filed with the Securities and Exchange Commission (SEC) its quarterly report on Form 10-Q for the 1st fiscal quarter ended June 30, 2025.

Loar Holdings Inc. Reports Q2 2025 Record Results and Upward Revision to 2025 Outlook and Announces the Acquisition of Beadlight Ltd.

WHITE PLAINS, NY / ACCESS Newswire / August 13, 2025 / Loar Holdings Inc. (NYSE:LOAR) (the "Company," "Loar," "we," "us" and "our"), reports record results for the second quarter of 2025, upward revision to 2025 guidance, and announces the acquisition of Beadlight Ltd. ("Beadlight").

Wellgistics Health (NASDAQ: WGRX) Launches XRP Payment Program for Independent Pharmacies

TAMPA, FLORIDA / ACCESS Newswire / August 13, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the launch of its Ripple Labs-powered XRP Implementation Program, giving independent pharmacies access to blockchain-based payments in the prescription drug space for the first time. The program enables pharmacies to pay for products and move funds instantly, more cost-effectively, and with full transparency-eliminating delays, high fees, and reliance on traditional banking and credit card networks. Wellgistics Health is among the first healthcare companies to implement an XRP-based payment solution at scale.

1606 Corp. (CBDW) Announces Successful 10-Q Filing, Increased Market Activity, and Active M&A Strategy

SEATTLE, WA / ACCESS Newswire / August 13, 2025 / 1606 Corp. (the "Company") (OTCID:CBDW) is pleased to announce the timely filing of its Quarterly Report on Form 10-Q for the second quarter of 2025. This filing highlights the Company's continued commitment to transparency, regulatory compliance, and delivering consistent shareholder updates. The Company believes these factors and its continued development make 1606 Corp. a valuable and sought after public entity in a great position for future growth.

Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl

RED BANK, NEW JERSEY / ACCESS Newswire / August 13, 2025 / Tharimmune, Inc. (Nasdaq:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates for inflammation, immunology, and critical unmet medical needs, today announced a significant expansion of its intellectual property portfolio for TH-104, its novel transmucosal film. The new patents, recently granted and allowed across key global markets, will enable the Company's long-term strategy of pursuing broader indications for the technology, beginning with its lead program as a critical medical countermeasure for military and first responders against high-potency opioids.

TSS, Inc. Announces Pricing of $51 Million Public Offering of Common Stock

GEORGETOWN, TEXAS / ACCESS Newswire / August 13, 2025 / TSS, Inc. (Nasdaq:TSSI) (the "Company" or "TSS"), a data center services company that provides AI and high-performance computing infrastructure and software integration services, today announced the pricing of its previously announced underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $17.00 per share of common stock, before deducting underwriting discounts and commissions and offering expenses. The Company intends to use the net proceeds from this offering for general corporate purposes, including, but not limited to, working capital and growth capital.

Xenetic Biosciences, Inc. Reports Second Quarter 2025 Financial Results

Expanded strategic partnership with The Scripps Research Institute to advance proof-of-concept studies and further develop its program combining systemic DNase I with CAR T-cell therapiesEnded the quarter with $4.8 million of cash to fund operations

Argyle IT Solutions Ranks No. 2,407 on the 2025 Inc. 5000 List of America's Fastest-Growing Private Companies

With Three-Year Revenue Growth of 179 Percent, This Marks Argyle IT Solutions' First Time on the List

Ondas Holdings Inc. Prices Upsized $150 Million Public Offering of Common Stock

BOSTON, MASSACHUSETTS / ACCESS Newswire / August 13, 2025 / Ondas Holdings Inc. (NASDAQ:ONDS) ("Ondas" or the "Company"), a leading provider of private industrial wireless networks and commercial drone and automated data solutions through its Ondas Networks and Ondas Autonomous Systems business units, announced today that it has priced its underwritten public offering of 46,160,000 shares of its common stock. The public offering price of each share of common stock is $3.25. Ondas expects the gross proceeds from this offering to be $150 million, before deducting the underwriting discount and other estimated offering expenses. Ondas intends to use the net proceeds from this offering for working capital, general corporate purposes and potential strategic transactions, including acquisitions of businesses or assets, joint ventures or investments in businesses, products or technologies. Ondas has granted the underwriters a 30-day option to purchase up to 6,924,000 additional shares of its common stock. Ondas expects to close the offering, subject to the satisfaction of customary conditions, on or about August 14, 2025.

SideChannel Reports Third Quarter Results

Financial results conference call on Wednesday, August 13 @ 4:30 P.M. ET

Aspira Announces Second Quarter 2025 Financial Results and Provides Business Update

AUSTIN, TX / ACCESS Newswire / August 13, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasive gynecologic disease diagnostic and disease management tools, announced today its results of operations for the three and six months ended June 30, 2025. The Company also reported early progress under its new leadership team.

Ryde Announces Strategic Partnership with Concorde to Drive Cross-Sector Workforce Transformation in Singapore

Potential to Unlock Significant New Revenue Opportunities for Both Companies and Driver-Partners

AI(4) Announces Next Evolution of Agentic AI - The First Token That Learns

Community-driven AI ecosystem merges live market data, autonomous reasoning, and blockchain incentives to create the world's first adaptive intelligence powered by its own token economy.

eXoZymes Provides Second Quarter 2025 Update at 5PM EST Today

Management to host earnings call at 5:00PM Eastern Time, today.

TSS Inc. Announces Proposed Public Offering of Common Stock

GEORGETOWN, TX / ACCESS Newswire / August 12, 2025 / TSS, Inc. (Nasdaq:TSSI) (the "Company" or "TSS") a data center services company that integrates AI and other high-performance computing infrastructure and software and provides related data center services, today announced that it is commencing an underwritten public offering of shares of its common stock. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

CXApp Inc. (Nasdaq: CXAI) Reports Solid Q2'25 Results and Increased Adoption of Agentic AI based CXAI Platform

Largest ARR Renewal with Fortune 50 client and expansion of agentic AI based products and solutionsAgentic AI partnership with Google leading to disruptive product offerings

Ondas Holdings Inc. Announces Proposed Public Offering of Common Stock

BOSTON, MA / ACCESS Newswire / August 12, 2025 / Ondas Holdings Inc. (NASDAQ:ONDS) ("Ondas" or the "Company"), a leading provider of private industrial wireless networks and commercial drone and automated data solutions through its Ondas Networks and Ondas Autonomous Systems business units, today announced that it intends to offer and sell shares of its common stock. Ondas also expects to grant the underwriters a 30-day option to purchase additional shares of common stock offered in the public offering. All of the shares in the proposed offering are to be sold by Ondas. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Ondas intends to use the net proceeds from the proposed offering for working capital, general corporate purposes and potential strategic transactions, including acquisitions of businesses or assets, joint ventures or investments in businesses, products or technologies.

ParkerVision Reports Second Quarter 2025 Results

JACKSONVILLE, FL / ACCESS Newswire / August 12, 2025 / ParkerVision, Inc. (OTCQB:PRKR) ("ParkerVision" or the "Company"), a developer and marketer of technologies and products for wireless applications, today announced results for the three and six months ended June 30, 2025.

Intelligent Protection Management Corp. Reports Second Quarter 2025 Financial Results

Q2 Total Revenue: $5.7 million; Six Months Total Revenue: $11.2 millionCash Flow from Operations for 1H 2025: $0.9 millionCash and Equivalents: $8.3 million, including Restricted Cash of $1.0 millionNo Long-Term DebtInvestor Conference Call TODAY at 4:30 p.m. Eastern Time

Intrusion Inc. Reports Second Quarter 2025 Results

Recent Intrusion Shield expansion highlights progress toward sustainable growth and profitability

ClearPoint Neuro Reports Second Quarter 2025 Results

Record Revenue and Substantial Cash Infusion Highlight the Company's ‘Fast. Forward.' Strategy

Orior Media Bridges Creativity and AI to Deliver Intelligent Marketing at Scale

PHOENIX, ARIZONA / ACCESS Newswire / August 12, 2025 / Orior Media is raising the bar and rewriting the playbook. With the launch of its newly redesigned website and a suite of proprietary tools, the agency is making bold moves to become the first AI-powered, tech-oriented marketing agency specializing in the U.S. transportation and logistics sector.

Dr. Roy Levitt, Executive Chairman of Adolore BioTherapeutics, Presented at the Next Generation Gene Therapy Vectors Summit

DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, Principal Investigator and Program Director of the NIH, NINDS, HEAL UH3 Award supporting ADB-102 development for the treatment of chronic knee pain due to osteoarthritis, ("OA"), and founder and Executive Chairman of Adolore presented the Company's breakthrough non-opioid gene therapy programs for chronic pain at the Next Generation Gene Therapy Vectors Summit on July 31, 2025 in Boston.

InHand Networks Introduces the CPE02: Powering Business Networks with High-Speed Connectivity and Smart Management

High-speed 5G, Wi-Fi 6, intelligent failover, and cloud management - now certified for seamless use on leading U.S. networks.

AI Maverick Intel Provides Corporate Update

NEW YORK CITY, NEW YORK / ACCESS Newswire / August 12, 2025 / AI Maverick Intel Inc. (OTCID:BINP), a technology-driven innovator focused on redefining how businesses acquire and engage customers through artificial intelligence, today provided a corporate update. On July 30, 2025, the Company announced its selection of IBN, a leading multi-channel financial news and publishing platform serving both private and public companies, to direct AI Maverick Intel's corporate communications. Earlier today, IBN released its first feature on the Company, which is presented in full below.

Rain Enhancement Technologies Strengthens Board of Directors with Appointment of Industry Veterans Bob Reardon and Marc Peperzak

Insurance and Agriculture Leaders Bring Decades of Experience in Key Target Markets for Rainfall Generation Technology

WanAware Survey Finds ITAM Confidence Gap is Costing Enterprises Time, Trust, and Millions in Missed Value

New survey of 600 enterprise leaders reveals growing investment in IT asset management, yet alarming visibility and alignment gaps persist across organizations.

Cubic, ShootHouse and Digimation to Provide a Family of System Integrated Products to the Middle East and Singapore

Delivering cost-effective simulation training solutions to improve proficiency and critical decision-making skills

FlyGuys Named to Inc. 5000's List of Fastest-Growing Companies

Reality data platform powering AI innovation makes huge leap in national, industry, and regional rankings

WidePoint to Participate in the H.C. Wainwright @ Home Fireside Chat on Tuesday, August 19, 2025 at 11:00 a.m. Eastern Time

FAIRFAX, VIRGINIA / ACCESS Newswire / August 12, 2025 / WidePoint Corporation(NYSE American:WYY), an innovative leader in enterprise cybersecurity and mobile technology, announced today that Jin Kang, WidePoint's Chief Executive Officer, will participate in the HCW @ Home fireside chat on Tuesday, August 19, 2025 at 11:00 a.m. Eastern time (8:00 a.m. Pacific time).

InnoSIGN Launches First-in-Class Portal to Identify Disease Drivers from Gene Expression Data

New platform empowers researchers and drug developers with secure, on-demand functional pathway analysis from RNA-seq data

IGC Pharma Highlights Alzheimer's Pipeline with Encouraging Preclinical Data on IGC-M3 and Advancing Phase 2 Cannabinoid-Based IGC-AD1

Positions IGC at the intersection of biotech innovation and cannabinoid science in one of the largest unmet medical needs in the worldAlzheimer's affects over 50 million people globally, with more than 400 million at risk from underlying disease pathology

Arizona Tribune - Technology (English)